Giuseppe Curigliano

European Institute of Oncology

Research Interests

Explore related searches

Contact this professor

Google Scholar

Articles (23)

Collaborators (13)

Carmen Criscitiello

Istituto Europeo di Oncologia

Giovanni Corso

University of Milan

Francesco Ceci

Assistant Professor

University of Milan

Chiara Corti

Harvard University

UNITED STATES

Shilpa Murthy

Assistant Professor of Surgery

Yale University

UNITED STATES

Paolo Tarantino

Dana-Farber Cancer Institute

UNITED STATES

ANTONIO PASSARO

European Institute of Oncology

Mariia Ivanova

University of Milan

Luca Boscolo Bielo

European Institute of Oncology

Franco Orsi

European Institute of Oncology

Lesley Fallowfield

Director, Professor of Psycho-oncology

University of Sussex

UNITED KINGDOM

Nicola Fusco

University of Milan

Liliana Ascione

Dana-Farber Cancer Institute

UNITED STATES

Giuseppe Curigliano

Research Interests

Explore related searches

Contact this professor

Articles (23)

Estrogen Signaling in Early-Stage Breast Cancer: Impact on Neoadjuvant Chemotherapy and Immunotherapy

Breast Immunology Network: Toward a Multidisciplinary and Integrated Model for Breast Cancer Care in Italy

Management of MET-Driven Resistance to Osimertinib in <i>EGFR</i>-Mutant Non-Small Cell Lung Cancer

Expert consensus on the prevention of brain metastases in patients with HER2-positive breast cancer

Expert recommendations on treatment sequencing and challenging clinical scenarios in human epidermal growth factor receptor 2-positive (HER2-positive) metastatic breast cancer

Metastasis-directed stereotactic radiotherapy and systemic treatment continuation for patients with oligoprogressive metastatic breast cancer

Early Breast Cancer Risk Assessment: Integrating Histopathology with Artificial Intelligence

The Evolving Role of Genomic Testing in Early Breast Cancer: Implications for Diagnosis, Prognosis, and Therapy

6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7)

Deciphering the Complex Interplay of Long Noncoding RNAs and Aurora Kinases: Novel Insights into Breast Cancer Development and Therapeutic Strategies

Beyond PD(L)-1 Blockade in Microsatellite-Instable Cancers: Current Landscape of Immune Co-Inhibitory Receptor Targeting

An international survey on the knowledge, attitudes and clinical patterns of use of medical cannabis for cancer care: The TASMAN study.

The Safety and Suitability of DNA Sequencing of Tissue Biopsies Performed on Patients Referred to a Phase I Unit

FDG and Non-FDG Radiopharmaceuticals for PET Imaging in Invasive Lobular Breast Carcinoma

Resistance to Antibody-Drug Conjugates Targeting HER2 in Breast Cancer: Molecular Landscape and Future Challenges

Breast Cancer with Brain Metastasis: Molecular Insights and Clinical Management

Targeting Post-Translational Modifications to Improve Combinatorial Therapies in Breast Cancer: The Role of Fucosylation

Unlocking the Resistance to Anti-HER2 Treatments in Breast Cancer: The Issue of HER2 Spatial Distribution

Tumor Infiltrating Lymphocytes across Breast Cancer Subtypes: Current Issues for Biomarker Assessment

Radiomic Features Applied to Contrast Enhancement Spectral Mammography: Possibility to Predict Breast Cancer Molecular Subtypes in a Non-Invasive Manner

PIK3CAMutations in Breast Cancer Subtypes Other Than HR-Positive/HER2-Negative

Targeting Cellular Components of the Tumor Microenvironment in Solid Malignancies

Implications of Oncology Trial Design and Uncertainties in Efficacy-Safety Data on Health Technology Assessments

Collaborators (13)

Carmen Criscitiello

Giovanni Corso

Francesco Ceci

Chiara Corti

Shilpa Murthy

Paolo Tarantino

ANTONIO PASSARO

Mariia Ivanova

Luca Boscolo Bielo

Franco Orsi

Lesley Fallowfield

Nicola Fusco

Liliana Ascione

How do I reach out?

Meet Kite AI